Richard M Hoglund

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Plasmodium Falciparum

Cervical Cancer Screening

Top Venues

CPT: pharmacometrics & systems pharmacology

Nature communications

PLoS neglected tropical diseases

Expert review of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Thanaporn Wattanakul, Mary Ellen Gilder, Rose McGready, Warunee Hanpithakpong, Nicholas P J Day, Nicholas J White, Francois H Nosten, Joel Tarning, Richard M Hoglund
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants. Nature communications 15 (1) (2024)
Thanaporn Wattanakul, Mary Ellen Gilder, Rose McGready, Warunee Hanpithakpong, Nicholas P J Day, Nicholas J White, Francois H Nosten, Joel Tarning, Richard M Hoglund
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants. Nature communications 15 (1) (2024)
Junjie Ding, Richard M Hoglund, Joel Tarning
Medication adherence framework: A population-based pharmacokinetic approach and its application in antimalarial treatment assessments. CPT: pharmacometrics & systems pharmacology (2024)
Junjie Ding, Richard M Hoglund, Joel Tarning
Medication adherence framework: A population-based pharmacokinetic approach and its application in antimalarial treatment assessments. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Thanaporn Wattanakul, Mary Ellen Gilder, Rose McGready, Warunee Hanpithakpong, Nicholas P J Day, Nicholas J White, Francois H Nosten, Joel Tarning, Richard M Hoglund
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants. Nature communications 15 (1) (2024)
Junjie Ding, Richard M Hoglund, Joel Tarning
Medication adherence framework: A population-based pharmacokinetic approach and its application in antimalarial treatment assessments. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Junjie Ding, Richard M Hoglund, Joel Tarning
Medication adherence framework: A population-based pharmacokinetic approach and its application in antimalarial treatment assessments. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Junjie Ding, Richard M Hoglund, Joel Tarning
Medication adherence framework: A population-based pharmacokinetic approach and its application in antimalarial treatment assessments. CPT: pharmacometrics & systems pharmacology 13 (5) (2024)
Thanaporn Wattanakul, Mary Ellen Gilder, Rose McGready, Warunee Hanpithakpong, Nicholas P J Day, Nicholas J White, Francois H Nosten, Joel Tarning, Richard M Hoglund
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants. Nature communications 15 (1) (2024)
Frauke Assmus, Richard M Hoglund, Frédéric Monnot, Sabine Specht, Ivan Scandale, Joel Tarning
Drug development for the treatment of onchocerciasis: Population pharmacokinetic and adverse events modeling of emodepside. PLoS neglected tropical diseases 16 (3) (2022)
Thanaporn Wattanakul, Palang Chotsiri, Ivan Scandale, Richard M Hoglund, Joel Tarning
A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics. Expert review of clinical pharmacology 15 (8) (2022)
Nicholas J White, James A Watson, Richard M Hoglund, Xin Hui S Chan, Phaik Yeong Cheah, Joel Tarning
COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology. PLoS medicine 17 (9) (2020)
Lorenz von Seidlein, Borimas Hanboonkunupakarn, Podjanee Jittamala, Pongphaya Pongsuwan, Kesinee Chotivanich, Joel Tarning, Richard M Hoglund, Markus Winterberg, Mavuto Mukaka, Pimnara Peerawaranun, Pasathorn Sirithiranont, Zoe Doran, Christian F Ockenhouse, Karen Ivinson, Cynthia Lee, Ashley J Birkett, David C Kaslow, Pratap Singhasivanon, Nicholas P J Day, Arjen M Dondorp, Nicholas J White, Sasithon Pukrittayakamee
Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers. Human vaccines & immunotherapeutics 16 (1) (2019)